Moderna
MRNA
#290
Rank
HK$618.49 B
Marketcap
HK$1,529
Share price
-2.17%
Change (1 day)
712.19%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2026 (TTM): -HK$62.49

According to Moderna 's latest financial reports the company's current EPS (TTM) is -HK$62.63. In 2025 the company made an earnings per share (EPS) of -HK$56.99 an increase over its 2024 EPS that were of -HK$72.74.

EPS history for Moderna from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$62.499.65%
2025-HK$56.99-21.66%
2024-HK$72.74-25.04%
2023-HK$97.05-158.62%
2022HK$165.56-30.25%
2021HK$237.36-1660.82%
2020-HK$15.2125.32%
2019-HK$12.1336.87%
2018-HK$8.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36-183.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.15-165.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$7.78-112.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-HK$5.72-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$15.91-74.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$155.29-347.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-HK$26.10-58.32%๐Ÿ‡บ๐Ÿ‡ธ USA